1145A Phase 2, Open-Label, Multi-Center, Randomized Trial To Demonstrate The Pharmacokinetics Of LCP-Tacro Tablets Once Daily and Prograf Capsules Twice Daily In Adult De Novo Kidney Transplant Patients.
Phase of Trial: Phase II
Latest Information Update: 22 May 2015
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 03 Jul 2012 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 03 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 May 2011 Results presented at the American Transplant Congress -- 11th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History